-
1
-
-
0030764685
-
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
-
(1997)
J Infect Dis
, vol.176
, pp. 924-932
-
-
Pilgrim, A.K.1
Pantaleo, G.2
Cohen, O.J.3
Fink, L.M.4
Zhou, J.Y.5
Zhou, J.T.6
Bolognesi, D.P.7
Fauci, A.S.8
Montefiori, D.C.9
-
4
-
-
0030880410
-
The role of virologic and immunologic factors in mother-to-child transmission of HIV-1
-
(1997)
Am J Reprod Immunol
, vol.38
, pp. 197-200
-
-
Colognesi, C.1
Halapi, E.2
Jansson, M.3
Hodara, V.4
Steuer, G.5
Tresoldi, E.6
Leitner, T.7
Scarlatti, G.8
-
5
-
-
0027463698
-
Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: Correlation with clinical status and prognostic value
-
(1993)
J Infect Dis
, vol.167
, pp. 538-546
-
-
Robert-Guroff, M.1
Roilides, E.2
Muldoon, R.3
Venzon, D.4
Husson, R.5
Marshall, D.6
Gallo, R.C.7
Pizzo, P.A.8
-
7
-
-
9544239346
-
The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate
-
(1996)
J Virol
, vol.70
, pp. 6751-6758
-
-
Conley, A.J.1
Kessler II, J.A.2
Boots, L.J.3
McKenna, P.M.4
Schleif, W.A.5
Emini, E.A.6
Mark III, G.E.7
Katinger, H.8
Cobb, E.K.9
Lunceford, S.M.10
Rouse, S.R.11
Murthy, K.K.12
-
8
-
-
0032947286
-
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
-
(1999)
J Virol
, vol.73
, pp. 4009-4018
-
-
Mascola, J.R.1
Lewis, M.G.2
Stiegler, G.3
Harris, D.4
Vancott, T.C.5
Hayes, D.6
Louder, M.K.7
Brown, C.R.8
Sapan, C.V.9
Frankel, S.S.10
Lu, Y.11
Robb, M.L.12
Katinger, H.13
Birx, D.L.14
-
9
-
-
0033951746
-
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
-
(2000)
Nat Med
, vol.6
, pp. 207-210
-
-
Mascola, J.R.1
Stiegler, G.2
Vancott, T.C.3
Katinger, H.4
Carpenter, C.B.5
Hanson, C.E.6
Beary, H.7
Hayes, D.8
Frankel, S.S.9
Birx, D.L.10
Lewis, M.G.11
-
10
-
-
0033952103
-
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
-
(2000)
Nat Med
, vol.6
, pp. 200-206
-
-
Baba, T.W.1
Liska, V.2
Hofmann-Lehmann, R.3
Vlasak, J.4
Xu, W.5
Ayehunie, S.6
Cavacini, L.A.7
Posner, M.R.8
Katinger, H.9
Stiegler, G.10
Bernacky, B.J.11
Rizvi, T.A.12
Schmidt, R.13
Hill, L.R.14
Keeling, M.E.15
Lu, Y.16
Wright, J.E.17
Chou, T.C.18
Ruprecht, R.M.19
-
11
-
-
0026536771
-
Passive immunotherapy in AIDS: A randomized trial of serial human immunodeficiency virus-positive transfusion of plasma rich in p24 antibodies versus transfusion of seronegative plasma
-
(1992)
J Infect Dis
, vol.165
, pp. 364-368
-
-
Vittecoq, D.B.1
Mattlinger, D.B.2
Barré-Sinoussi, F.3
Courouce, A.M.4
Rouzioux, C.5
Doinel, C.6
Bary, M.7
Viard, J.P.8
Bach, J.F.9
Rouger, P.10
Lefrere, J.J.11
-
12
-
-
0027237524
-
Passive immunotherapy of advanced human immunodeficiency virus infection
-
(1993)
J Infect Dis
, vol.168
, pp. 298-305
-
-
Jacobson, J.M.1
Colman, N.2
Ostrow, N.A.3
Simson, R.W.4
Tomesch, D.5
Marlin, L.6
Rao, M.7
Mills, J.L.8
Clemens, J.9
Pronce, A.M.10
-
14
-
-
0033914939
-
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type I entry inhibitor PRO 542 in HIV-infected adults
-
(2000)
J Infect Dis
, vol.182
, pp. 326-329
-
-
Jacobson, J.M.1
Lowy, I.2
Fletcher, C.V.3
O'Neill, T.J.4
Tran, D.N.5
Ketas, T.J.6
Trkola, A.7
Klotman, M.E.8
Maddon, P.J.9
Olson, W.C.10
Israel, R.J.11
-
15
-
-
2042438703
-
-
submitted for publication
-
Antiviral activity of human neutralizing antibodies after passive infusion to HIV-1 infected humans
-
-
Stiegler, G.1
Armbruster, C.2
Vcelar, B.3
Stoiber, H.4
Kunert, R.5
Michael, N.L.6
Jagodzinski, L.L.7
Amman, C.8
Jäger, W.9
Jacobson, J.10
Vetter, N.11
Katinger, H.12
-
16
-
-
0030985017
-
Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials
-
AIDS Clinical Trials Group Antibody Selection Working Group
-
(1997)
J Infect Dis
, vol.175
, pp. 1056-1062
-
-
D'Souza, M.P.1
Livnat, D.2
Bradac, J.A.3
Bridges, S.H.4
-
17
-
-
0028155283
-
Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization
-
(1994)
AIDS Res Hum Retroviruses
, vol.10
, pp. 359-369
-
-
Buchacher, A.1
Predl, R.2
Strutzenberger, K.3
Steinfellner, W.4
Trkola, A.5
Purtscher, M.6
Gruber, G.7
Tauer, C.8
Steindl, F.9
Jungbauer, A.10
Katinger, H.11
-
18
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
(1994)
Science
, vol.266
, pp. 1024-1027
-
-
Burton, D.R.1
Pyati, J.2
Koduri, R.3
Sharp, S.J.4
Thornton, G.B.5
Parren, P.W.6
Sawyer, L.S.7
Hendry, R.M.8
Dunlop, N.9
Nara, P.L.10
Lamacchia, M.11
Garratty, E.12
Stiehm, E.R.13
Bryson, Y.J.14
Cao, Y.15
Moore, J.P.16
Ho, D.D.17
Barbas III, C.F.18
-
19
-
-
0028865465
-
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies tetrameric CD4-IgG
-
(1995)
J Virol
, vol.69
, pp. 6609-6617
-
-
Trkola, A.1
Pomales, A.B.2
Yuan, H.3
Korber, B.4
Maddon, P.J.5
Allaway, G.P.6
Katinger, H.7
Barbas III, C.F.8
Burton, D.R.9
Ho, D.D.10
Moore, J.P.11
-
21
-
-
0028593629
-
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1
-
(1994)
AIDS Res Hum Retroviruses
, vol.10
, pp. 1651-1658
-
-
Purtscher, M.1
Trkola, A.2
Gruber, G.3
Buchacher, A.4
Predl, R.5
Steindl, F.6
Tauer, C.7
Berger, R.8
Barrett, N.9
Jungbauer, A.10
Katinger, H.11
-
22
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
(1996)
J Virol
, vol.70
, pp. 1100-1108
-
-
Trkola, A.1
Purtscher, M.2
Muster, T.3
Ballaun, C.4
Buchacher, A.5
Sullivan, N.6
Srinivasan, K.7
Sodroski, J.8
Moore, J.P.9
Katinger, H.10
-
26
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
-
(1993)
J Virol
, vol.67
, pp. 6642-6647
-
-
Muster, T.1
Steindl, F.2
Purtscher, M.3
Trkola, A.4
Klima, A.5
Himmler, G.6
Rüker, F.7
Katinger, H.8
-
29
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay2
-
30
-
-
0034759882
-
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glyoprotein gp 41
-
(2001)
J Virol
, vol.75
, pp. 10892-10905
-
-
Zwick, M.B.1
Labrijn, A.F.2
Wang, M.3
Spenlehauer, C.4
Saphire, E.O.5
Binley, J.M.6
Moore, J.P.7
Stiegler, G.8
Katinger, H.9
Burton, D.R.10
Parren, P.W.11
-
31
-
-
2042479023
-
Common sequence in HIV-1 gp41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection
-
(1991)
Adv Exp Med Biol
, vol.63
, pp. 303-309
-
-
Blackburn, R.1
Clerici, M.2
Mann, D.3
Lucey, D.R.4
Goedert, J.5
Golding, B.6
Shearer, G.M.7
Golding, H.8
-
33
-
-
0025253117
-
Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 3185-3189
-
-
Robinson Jr., W.E.1
Kawamura, T.2
Gorny, M.K.3
Lake, D.4
Xu, J.Y.5
Matsumoto, Y.6
Sugano, T.7
Masuho, Y.8
Mitchell, W.M.9
Hersh, E.10
Zolla-Pazner, S.11
-
35
-
-
0031729823
-
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
-
(1998)
Nat Med
, vol.4
, pp. 1302-1307
-
-
Kilby, J.M.1
Hopkins, S.2
Venetta, T.M.3
DiMassimo, B.4
Cloud, G.A.5
Lee, J.Y.6
Alldredge, L.7
Hunter, E.8
Lambert, D.9
Bolognesi, D.10
Matthews, T.11
Johnson, M.R.12
Nowak, M.A.13
Shaw, G.M.14
Saag, M.S.15
-
36
-
-
0034971817
-
Potent neutralization of primary HIV clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B
-
(2001)
J Hum Virol
, vol.4
, pp. 55-61
-
-
Xu, W.1
Smith-Franklin, B.A.2
Li, P.L.3
Wood, C.4
He, J.5
Du, Q.6
Bhat, G.J.7
Kankasa, C.8
Katinger, H.9
Cavacini, L.A.10
Posner, M.R.11
Burton, D.R.12
Chou, T.C.13
Ruprecht, R.M.14
-
37
-
-
0034685037
-
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society - USA Panel
-
(2000)
JAMA
, vol.283
, pp. 381-390
-
-
Carpenter, C.C.1
Cooper, D.A.2
Fischl, M.A.3
Gatell, J.M.4
Gazzard, B.G.5
Hammer, S.M.6
Hirsch, M.S.7
Jacobsen, D.M.8
Katzenstein, D.A.9
Montaner, J.S.10
Richman, D.D.11
Saag, M.S.12
Schechter, M.13
Schooley, R.T.14
Thompson, M.A.15
Vella, S.16
Yeni, P.G.17
Volberding, P.A.18
-
38
-
-
17344390474
-
Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
-
International AIDS Society - USA Panel
-
(1998)
JAMA
, vol.279
, pp. 1984-1991
-
-
Hirsch, M.S.1
Conway, B.2
D'Aquila, R.T.3
Johnson, V.A.4
Brun-Vezinet, F.5
Clotet, B.6
Demeter, L.M.7
Hammer, S.M.8
Jacobsen, D.M.9
Kuritzkes, D.R.10
Loveday, C.11
Mellors, J.W.12
Vella, S.13
Richman, D.D.14
|